Published in Hepatitis Weekly, March 24th, 2008
"This study assessed the safety and immunogenicity of coadministered quadrivalent HPV-6/11/16/18 L1 VLP and HBV vaccines in women (n = 1877) aged 16-23 years. Co-administration of HPV and HBV vaccines induced robust anti-HPV-6,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.